Patents Assigned to Translatum Medicus Inc.
-
Patent number: 11992534Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: August 3, 2021Date of Patent: May 28, 2024Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd
-
Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
Patent number: 11753382Abstract: The invention in this disclosure is related to the processes of making Bindarit or derivatives thereof. Specifically, the present invention provides, in part, new processes for making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives. By way of non-limiting example, synthesis and purification processes of 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid are provided by the invention in this disclosure.Type: GrantFiled: June 24, 2020Date of Patent: September 12, 2023Assignee: TRANSLATUM MEDICUS INC.Inventors: Xiangdong Jiao, Kanjai Khumtaveeporn -
Patent number: 11610311Abstract: Disclosed herein are computer systems for, in part, image processing. Also disclosed herein are systems for processing ocular images of multiple imaging modalities to detect ocular diseases. Also disclosed herein are method comprising systems as described herein.Type: GrantFiled: October 13, 2017Date of Patent: March 21, 2023Assignee: Translatum Medicus, Inc.Inventors: Shelley Boyd, Natalie Pankova
-
Patent number: 11110184Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: November 26, 2019Date of Patent: September 7, 2021Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd
-
Patent number: 10646592Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: February 19, 2019Date of Patent: May 12, 2020Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd
-
Patent number: 10537647Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: March 27, 2018Date of Patent: January 21, 2020Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd
-
Patent number: 10420848Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: May 14, 2018Date of Patent: September 24, 2019Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd
-
Patent number: 10265418Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: May 24, 2017Date of Patent: April 23, 2019Assignee: TRANSLATUM MEDICUS INC.Inventor: Shelley Romayne Boyd
-
Publication number: 20180221339Abstract: Disclosed herein are methods, compounds, and compositions that are useful for the diagnosis, treatment, or prevention of an ocular disorder, including in the discovery of agents that are efficacious against these disorders.Type: ApplicationFiled: June 16, 2016Publication date: August 9, 2018Applicant: TRANSLATUM MEDICUS, INC.Inventor: Shelley Romayne BOYD
-
Patent number: 9999688Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: April 12, 2017Date of Patent: June 19, 2018Assignee: TRANSLATUM MEDICUS INC.Inventor: Shelley Romayne Boyd
-
Patent number: 9820969Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: August 15, 2016Date of Patent: November 21, 2017Assignee: TRANSLATUM MEDICUS INC.Inventor: Shelley Romayne Boyd
-
Patent number: 9662407Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: March 3, 2015Date of Patent: May 30, 2017Assignee: TRANSLATUM MEDICUS INC.Inventor: Shelley Romayne Boyd
-
Patent number: 9370484Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: March 3, 2015Date of Patent: June 21, 2016Assignee: TRANSLATUM MEDICUS INC.Inventor: Shelley Romayne Boyd
-
Patent number: 8999292Abstract: This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA).Type: GrantFiled: March 15, 2013Date of Patent: April 7, 2015Assignee: Translatum Medicus Inc.Inventor: Shelley Romayne Boyd